Skin Diseases Clinical Trial
Official title:
Chia Nan University of Pharmacy & Science
Verified date | March 2022 |
Source | Chia Nan University of Pharmacy & Science |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the study was to use probiotic beauty products for 4 weeks and evaluate the impact of products on healthy skin.
Status | Completed |
Enrollment | 20 |
Est. completion date | August 15, 2020 |
Est. primary completion date | August 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 65 Years |
Eligibility | Inclusion Criteria: Healthy volunteers aged above 20 years old Exclusion Criteria: 1. Subject with diseases of the skin, heart, liver, kidney, endocrine and other organs and patients with mental illness (according to medical history). 2. Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder. 3. Female who is pregnant or nursing or planning to become pregnant during the course of the study. 4. Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks. 5. Involuntary subject 6. People who is taking chronic disease medication |
Country | Name | City | State |
---|---|---|---|
Taiwan | Chia Nan University of Pharmacy & Science | Tainan |
Lead Sponsor | Collaborator |
---|---|
Chia Nan University of Pharmacy & Science | Glac Biotech Co., Ltd |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Effects of the TAC/Collagen Gel on Human Skin Hydration | Corneometer® CM825 was utilized to measure skin moisture. Units: arbitrary Corneometer® units 0-120 | Subjects will be tested in the 4th week | |
Primary | Effects of the TAC/Collagen Gel on Human Skin Sebum | Callegari 1930 was utilized to measure skin inflammation. Units: arbitrary units. | Subjects will be tested in the 4th week | |
Primary | Effects of the TAC/Collagen gel on Human Skin Inflammation | Chroma Meter MM-500 was utilized to measure skin inflammation. Units: arbitrary units. | Subjects will be tested in the 4th week | |
Primary | Effect of TAC/Collagen Gel on Human Acne Healing and Porphyrins Numbers | VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units | Subjects will be tested in the 4th week | |
Primary | Effects of the TAC/Collagen Gel on Human Skin Brown Spot Numbers | VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units | Subjects will be tested in the 4th week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05038982 -
Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin
|
Phase 2 | |
Completed |
NCT03563066 -
Effect of Benralizumab in Atopic Dermatitis
|
Phase 2 | |
Recruiting |
NCT04818138 -
BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort
|
N/A | |
Recruiting |
NCT05102396 -
Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?
|
Phase 2 | |
Completed |
NCT02916888 -
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
|
N/A | |
Completed |
NCT00772447 -
China Registration Study in Patients With Skin Infections
|
Phase 3 | |
Recruiting |
NCT01631617 -
Effects of Treatments on Atopic Dermatitis
|
Phase 2 | |
Active, not recruiting |
NCT04971200 -
Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo
|
Early Phase 1 | |
Completed |
NCT04144491 -
Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda
|
N/A | |
Recruiting |
NCT04138342 -
Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer
|
Phase 1 | |
Recruiting |
NCT06061471 -
To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis
|
Phase 2 | |
Terminated |
NCT04775316 -
Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety of a Silicone-coated Transparent Postoperative Dressing
|
||
Recruiting |
NCT05765461 -
Effect of Lipikar Baume AP+M on Quality of Life and Pain of Adults With Dryness or Severe Xerosis
|
||
Withdrawn |
NCT04593914 -
A Novel Skin Barrier Protectant for Acute Radiodermatitis
|
N/A | |
Completed |
NCT03720470 -
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
|
Phase 3 | |
Recruiting |
NCT06092866 -
Digital Versus Telephone Symptom Assessment and Triage in Primary Care
|
N/A | |
Recruiting |
NCT04901325 -
Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
|
Phase 2 | |
Recruiting |
NCT01917279 -
Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC
|
Phase 3 | |
Completed |
NCT01975038 -
Adaption of the Skin Sun Sensitivity Scale
|
N/A | |
Recruiting |
NCT01427400 -
The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction
|
Phase 4 |